Homebiotech

biotech

Stay Connected
- Advertisement -spot_img
Latest Articles

Topline results from metastatic breast cancer phase 3 trial

BioNTech SE and DualityBiologics (Suzhou) Co., Ltd. have announced that the DYNASTY-Breast02 global phase 3 clinical trial met its primary endpoint. This demonstrated a statistically...